Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages.

[1]  T. Ottenhoff,et al.  Innate Immunity to Mycobacterium tuberculosis , 2002, Clinical Microbiology Reviews.

[2]  C. Dye,et al.  Tuberculosis control in the era of HIV , 2005, Nature Reviews Immunology.

[3]  M. Reed,et al.  A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response , 2004, Nature.

[4]  T. Shim,et al.  Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection. , 2003, Tuberculosis.

[5]  B. Gicquel,et al.  Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature‐tagged transposon mutagenesis , 1999, Molecular microbiology.

[6]  R. Young,et al.  T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. , 1997, Journal of immunology.

[7]  P. Allavena,et al.  Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells1 , 2000, The Journal of Immunology.

[8]  I. Smith,et al.  Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence , 2003, Clinical Microbiology Reviews.

[9]  M. Rojas,et al.  Functional and phenotypic changes in monocytes from patients with tuberculosis are reversed with treatment. , 2006, Microbes and infection.

[10]  T. Whittam,et al.  Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Roholl,et al.  Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model , 2004, Clinical and experimental immunology.

[12]  Stefan Niemann,et al.  Variable host-pathogen compatibility in Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Golenbock,et al.  Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. , 1999, Journal of immunology.

[14]  M. Reed,et al.  Differential Monocyte Activation Underlies Strain-Specific Mycobacterium tuberculosis Pathogenesis , 2004, Infection and Immunity.

[15]  M. Olivier,et al.  TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. , 1999, Journal of immunology.

[16]  G. Kaplan,et al.  Strain-specific mycobacterial lipids and the stimulation of protective immunity to tuberculosis. , 2005, Tuberculosis.

[17]  P. Barnes,et al.  Type 1 cytokines and the pathogenesis of tuberculosis. , 2000, American journal of respiratory and critical care medicine.

[18]  J. Gómez-Reino,et al.  Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. , 2003, Arthritis and rheumatism.

[19]  G. Rook,et al.  The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. , 1987, Immunology.

[20]  S. Akira,et al.  Limited role of the Toll‐like receptor‐2 in resistance to Mycobacterium avium , 2004, Immunology.

[21]  M. Reed,et al.  In vivo phenotypic dominance in mouse mixed infections with Mycobacterium tuberculosis clinical isolates. , 2005, The Journal of infectious diseases.

[22]  D. van Soolingen,et al.  A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes , 2003, Clinical and experimental immunology.

[23]  M. Rojas,et al.  Differential induction of apoptosis and necrosis in monocytes from patients with tuberculosis and healthy control subjects. , 2004, The Journal of infectious diseases.

[24]  E. Julián,et al.  Distribution of surface-exposed antigenic glycolipids in recent clinical isolates of Mycobacterium tuberculosis. , 1997, Research in microbiology.

[25]  B. Ryffel,et al.  Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. , 2004, The American journal of pathology.

[26]  Midori Kato-Maeda,et al.  Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  N. Reiling,et al.  Cutting Edge: Toll-Like Receptor (TLR)2- and TLR4-Mediated Pathogen Recognition in Resistance to Airborne Infection with Mycobacterium tuberculosis1 , 2002, The Journal of Immunology.

[28]  M. Luquin,et al.  Application of an easy and reliable method for sulfolipid-I detection in the study of its distribution in Mycobacterium tuberculosis strains. , 2000, FEMS microbiology letters.

[29]  A. Aderem,et al.  Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Fenton,et al.  The role of Toll-like receptors in immunity against mycobacterial infection. , 2002, Microbes and infection.

[31]  A. Sher,et al.  Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  William R. Jacobs,et al.  Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice , 1999, Nature.

[33]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[34]  D. van Soolingen,et al.  Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes , 2005, Clinical and experimental immunology.

[35]  M. Reed,et al.  Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. , 2005, The Journal of infectious diseases.

[36]  Younghee Lee,et al.  Direct role of NF‐κB activation in Toll‐like receptor‐triggered HLA‐DRA expression , 2006, European journal of immunology.

[37]  H. Debbabi,et al.  Toll-Like Receptor 4-Defective C3H/HeJ Mice Are Not More Susceptible than Other C3H Substrains to Infection with Mycobacterium tuberculosis , 2003, Infection and Immunity.

[38]  C. Harding,et al.  The Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and FcγR1 on Human Macrophages through Toll-Like Receptor 2 , 2003, Infection and Immunity.

[39]  David G. Russell,et al.  Mycobacterium and the coat of many lipids , 2002, The Journal of cell biology.

[40]  J. Ellner,et al.  Expression of Virulence of Mycobacterium tuberculosiswithin Human Monocytes: Virulence Correlates with Intracellular Growth and Induction of Tumor Necrosis Factor Alpha but Not with Evasion of Lymphocyte-Dependent Monocyte Effector Functions , 1998, Infection and Immunity.

[41]  M. Daffé,et al.  Structure of a novel sulfate-containing mycobacterial glycolipid. , 1992, Biochemistry.

[42]  P. Salgame.  Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. , 2005, Current opinion in immunology.

[43]  B. Bloom,et al.  Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. , 1999, Science.

[44]  C. Barry,et al.  Interpreting cell wall 'virulence factors' of Mycobacterium tuberculosis. , 2001, Trends in microbiology.

[45]  B. Abomoelak,et al.  Identification of a diacylglycerol acyltransferase gene involved in accumulation of triacylglycerol in Mycobacterium tuberculosis under stress. , 2006, Microbiology.

[46]  J. Keane,et al.  Differential Effects of a Toll-Like Receptor Antagonist on Mycobacterium tuberculosis-Induced Macrophage Responses1 , 2001, The Journal of Immunology.

[47]  Gilla Kaplan,et al.  Immunopathologic Effects of Tumor Necrosis Factor Alpha in Murine Mycobacterial Infection Are Dose Dependent , 2000, Infection and Immunity.

[48]  D. Kusner.  Mechanisms of mycobacterial persistence in tuberculosis. , 2005, Clinical immunology.

[49]  J. Heuser,et al.  Trafficking and Release of Mycobacterial Lipids from Infected Macrophages , 2000, Traffic.

[50]  Peter M. Small,et al.  The W-Beijing Lineage of Mycobacterium tuberculosis Overproduces Triglycerides and Has the DosR Dormancy Regulon Constitutively Upregulated , 2007, Journal of bacteriology.

[51]  C. Harding,et al.  Mycobacterium tuberculosis LprA Is a Lipoprotein Agonist of TLR2 That Regulates Innate Immunity and APC Function1 , 2006, The Journal of Immunology.

[52]  A. Azad,et al.  Biochemistry and molecular genetics of cell‐wall lipid biosynthesis in mycobacteria , 1997, Molecular microbiology.

[53]  P. Godowski,et al.  Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines , 2002, The Journal of Immunology.

[54]  S. Akira,et al.  IL-6 and IL-10 Induction from Dendritic Cells in Response to Mycobacterium tuberculosis Is Predominantly Dependent on TLR2-Mediated Recognition1 , 2004, The Journal of Immunology.

[55]  P. Gounon,et al.  Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species , 1996, Journal of bacteriology.

[56]  B. Ryffel,et al.  Innate immunity to mycobacterial infection in mice: critical role for toll-like receptors. , 2005, Tuberculosis.

[57]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[58]  B. Ryffel,et al.  Toll-Like Receptor 4 Expression Is Required to Control Chronic Mycobacterium tuberculosis Infection in Mice1 , 2002, The Journal of Immunology.

[59]  Vojo Deretic,et al.  Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[60]  S. Akira,et al.  [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.

[61]  Denise E Kirschner,et al.  Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages. , 2005, Proceedings of the National Academy of Sciences of the United States of America.